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It is heartening to learn from recent data in multiple settings
that decreasing community viral load through “universal test
and treat” programmes is having a significant impact on HIV
morbidity, mortality and the rate of new HIV infections in
some settings [1-3]. However, focusing only on preventing
transmission from a person already living with HIV to one who
is not, is only half of the equation and will by itself not “end
HIV.” A crucial focus remains preventing acquisition of HIV
infection among people at risk. Achieving this requires that we
strengthen primary HIV prevention programmes because HIV
incidence declines attributable to treatment may be slower
than required to meet global goals [4]; treatment as preven-
tion may have less impact where a high proportion of trans-
mission involves those in early stage HIV infection [5]; and,
critically, because it is essential that individuals and communi-
ties have the autonomy to avoid acquiring HIV if at all possi-
ble.
Happily, the range of efficacious tools for primary prevention
of HIV infection has increased in recent years. These include
condoms, voluntary medical male circumcision, oral pre-expo-
sure prophylaxis (PrEP), clean needles and associated drug use
paraphernalia, as well as a range of behaviours, such as infor-
mation sharing between partners about HIV serostatus, use of
antiretroviral therapy (ART), or HIV viral load before making
decisions about sex and drug-using activities. However, opti-
mism must be tempered by the fact that, although some tools
have been with us for some time, their population impact has
been limited by individual, interpersonal, social (including cul-
tural, economic and political) and structural factors.
The aim of a primary HIV prevention programme is to
increase the uptake and continued use of efficacious HIV pre-
vention tools and other safe behaviours among those who
may be at risk of infection. Achieving this requires strategies
that are appropriate, acceptable and reach those in need. Pro-
grammers can only know how well they are doing in this
regard by collecting and using data in a systematic way. This
special issue of Journal of the International AIDS Society
showcases current thinking on how data can be used to sup-
port decision makers in deploying their resources to maximize
the impact of primary HIV prevention programmes.
Formulating an HIV prevention strategy includes a range of
considerations: whether and how to focus efforts to particular
populations versus implementing a general population
approach; which prevention tools to offer; and, the extent to
which the programme should focus on strengthening motiva-
tion for HIV prevention behaviours, improving supply chan-
nels, and/or supporting the capacity of individuals to enact
HIV avoidance behaviours. Data-informed insights are needed
to support these decisions. The data must go beyond an
assessment of where and among whom new HIV infections
are occurring. Only by understanding the modifiable determi-
nants of risk and barriers to prevention can programmers
select, implement, monitor and strengthen the most appropri-
ate interventions and policies.
This is not a new call. More than 10 years ago, "know your
epidemic, know your response" was positioned as a "rallying
cry" for an intensified HIV prevention response [6]. The need
to renew this message periodically reflects the reality that the
measurement challenges we face in HIV prevention are for-
midable, the determinants of HIV risk are multiple, complex
and interacting, and the barriers to sustained behaviour
change significant. It is clear that interdisciplinary research
and data-driven multi-sectoral planning remain critical to
strengthening primary HIV prevention. The papers in this spe-
cial issue reflect the effort, innovation, and challenges faced
by those who share this vision today.
In responding to our call for papers on "Data-driven HIV
prevention," many (though not all) of the papers attempt to
operationalize an HIV prevention cascade. HIV prevention cas-
cades are a promising framework that can be used to gener-
ate insights from data in many instances. We were pleased to
see the innovation and thought reflected in the papers that
provided cascade models: nevertheless, there remains work to
do. As Auerbach et al. [7] outline, debates about the merits
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and pitfalls of HIV prevention cascades are ongoing, but there
is general agreement that a standardized programme monitor-
ing tool (like the treatment cascade) would be helpful. As the
authors note, emerging consensus identifies the core steps of
primary prevention cascade models for programme monitoring
and research as first characterizing the priority population at
risk, and then tracking motivation, access, uptake and/or effec-
tive use of prevention tools among this population. We use
this prevention cascade structure to provide a brief overview
of the content of this special issue.
Identifying priority populations for whom primary prevention
efforts are to be strengthened is the first job for any HIV preven-
tion strategy. Rice et al. [8] reflect on a pilot of tests of recent HIV
infection in diverse routine HIV testing settings in Kenya and
Zimbabwe and consider the potential use of these tests to help
focus prevention activities. Virkud et al. [9] generate cascades
that show the need for HIV prevention to be strengthened
among those who visit bars, hotels and guest houses in cross-
border areas in East Africa. Sibanda et al. [10] show that new HIV
infections among pregnant mothers are a critical driver of infant
infections in Zimbabwe and highlight the need to strengthen pre-
vention cascades among HIV-negative women.
HIV prevention programmes seek to increase individuals’
motivation to undertake behaviours that will protect them and
others from HIV infection. [11] The HIV prevention cascade
recognizes that the range of relevant behaviours include deci-
sions such as to avoid sex, take PrEP, suggest condom use to
a sexual partner, and be circumcised. An individual’s beha-
vioural intention is also influenced by perceived social norms.
Hill et al. [12] present data from one priority population –
adolescent girls and young women (AGYW) in Malawi – and
carefully examine the relationships between risk perception,
“epidemiological” risk, and the motivation of these young
women to take PrEP. They conclude that motivation remains
lower than optimal and more efforts are needed as PrEP rolls
out. Similarly, Ramautarsing et al. [13] used programmatic data
to document PrEP roll-out among transgender women and
men who have sex with men (MSM) in Thailand. They found
that the biggest gap in the cascade for both population groups
was in demand: many clients who were offered PrEP did not
initiate PrEP because they did not perceive themselves to be
at risk for HIV acquisition.
When people are motivated to use existing HIV prevention
methods, lack of access to them can have population-level
impacts on infection rates. The implications of poor access are
shown by a modelling exercise of couples’ voluntary coun-
selling and testing programmes, which can facilitate prevention
choices, in six African countries presented by Wall et al. [14]
When new methods, such as PrEP, are introduced, gains in
HIV prevention can be made through strengthening supply
channels and breaking down access barriers; but uptake takes
time and is influenced by attitudes and behaviours of provi-
ders and clients. Were et al. [15] use data from the first two
years of PrEP roll-out in Kenya to construct prevention cas-
cades and to highlight missed opportunities in PrEP delivery
and uptake among three priority populations – female sex
workers (FSW), MSM and AGYW. For AGYW, the biggest
missed opportunity was screening. For MSM and FSW, the
biggest missed opportunity was that, among those who were
screened and found eligible for PrEP, the majority did not initi-
ate PrEP despite its availability.
Even when people are motivated, have access to, and initi-
ate HIV prevention measures, social and structural barriers
may impede their capacity to use them consistently. Program-
matic innovation in addressing these barriers remains critical.
Chabata et al. [16] show that knowledge of condom efficacy is
high and availability good among young women who sell sex in
Zimbabwe, and yet consistent use is low, especially among
those young women who recently experienced violence from a
sexual partner. Holmes et al. [17] characterize the relationship
environments of young women in South Africa and how these
influence PrEP use/adherence, secondary distribution of HIV
self-tests to partners, and of sharing information about HIV
status. In a modelling study, Bershteyn et al. [18] demonstrate
how implementation challenges along the prevention cascade
differentially influence the population-level impacts of the use
of oral PrEP and long-acting PrEP in Kenya. Wilson et al. [19]
report on social and structural determinants and patterns of
PrEP use among two sexual minority populations – transgen-
der women and MSM in the United States. They find differ-
ences in the PrEP cascades for the two populations, with
transgender women being more affected by social-structural
issues of poverty, homelessness and unemployment than
MSM. Their paper underscores the need to distinguish and
specify priority populations, and to identify the particular HIV
prevention gaps, barriers and approaches relevant to each.
As Auerbach et al. [7] note, and the aforementioned exam-
ples attest, while the cascade model has proven to be useful
for monitoring progress and gaps in HIV prevention program-
ming in many settings, it does have limitations. Dumchev et al.
[20] present an analysis of data from an integrated bio-be-
havioural survey in Ukraine to assess the HIV prevention cas-
cade for people who inject drugs. They find that in their
context there was little consistency between their “access to
services” and “effective use” measures, given that people who
inject drugs often obtain sterile syringes from sources other
than the programmes being monitored.
Across the papers included in this special issue, authors are
striving for a strengthened feedback loop, from data to pro-
gramming decisions, for primary HIV prevention to support
implementers and managers to deploy the interventions that
are most needed to address the determinants of risk in their
settings. Most papers use existing data streams to populate
their cascade models, and many identify significant measure-
ment and interpretation challenges in operationalizing key ele-
ments of the cascade. Further innovation remains essential to
strengthen our capacity to track cascades and thereby
strengthen the right intervention mix. Generally, it is not feasi-
ble to create new data sources or make fundamental changes
to existing data sources to inform prevention programming.
However, more work would be useful to establish the extent
to which minor changes to routine data systems, including fur-
ther integration of qualitative enquiry, would be feasible for
different settings, populations and methods that would
improve the validity and utility of the cascades that can be
generated.
Most of the papers submitted for the special issue focussed
on single methods of prevention. To some extent this may
reflect the continuing siloing of programmes for different pre-
vention methods despite the common call for combination
prevention approaches [21]. In principle, it is quite possible to
create HIV prevention cascades for combination prevention
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[22] and we would encourage more attempts to do this. We
would also like to see a greater effort to bring HIV prevention
cascade thinking into modelling efforts that often guide pro-
gramme decision making. Again, a greater focus on qualitative
and participatory data enquiry that unpacks the reasons for
drop offs in the cascade, could also accelerate the loop from
data to programmatic improvement.
We applaud the authors of the papers in this series for
grappling with some thorny issues in primary HIV prevention
data collection and, particularly, cascade analysis. We hope
readers find this special issue helpful in their own efforts to
strengthen ongoing monitoring, evaluation and advocacy of
HIV prevention to meet global goals by 2030.
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